WION Fineprint: How effective is blood-thinning therapy for COVID patients?
According to a new study, the blood-thinning drug Apixaban puts patients at risk for no clear benefit. The drug has been used as a potential life-saver for those recovering from severe COVID-19. But the research suggests that it does not work and
UP NEXT
UP NEXT
-
Gravitas: Zelensky calls for Russia to be banned from Paris Olympics
WION
-
Gravitas: Iran Military Factory Attack
-
Gravitas Global Headlines: Heavy rain wreaks havoc in Auckland
-
Gravitas: Marie Kondo’s new messier mode
-
Gravitas: Adani Firms Lose $65 Billion
-
Gravitas: Anti-government Protests In Peru
-
Gravitas: Antony Blinken meets Netanyahu as Israel, Palestine tensions rise
-
Gravitas: Pakistan suicide blast: Over 47 dead, 100 injured
-
Report: US says UK army no longer a top-level fighting force
-
UK PM Rishi Sunak sacks Nadhim Zahawi, BBC Chief next?
-
Baidu plans to roll out AI-powered Chatbot
-
Peshawar Mosque Blast: At least 47 dead, over 150 injured
-
Boeing's 747, the original 'jumbo jet' prepares for final send-off
-
Ukrainian President Zelensky meets Danish PM Mette Frederiksen in Mykolaiv
-
WION Fineprint: Pakistan's perfect storm
-
WION Fineprint: Antony Blinken's West Asia visit
